相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between proton pump inhibitors use and risk of hip fracture: A general population-based cohort study
Jie Wei et al.
BONE (2020)
High fracture risk patients with glucocorticoid-induced osteoporosis should get an anabolic treatment first
E. Lespessailles et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Medications associated with fracture risk in patients with rheumatoid arthritis
Gulsen Ozen et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Secular trends in major osteoporotic fractures among 50+adults in Denmark between 1995 and 2010
Shahab Abtahi et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Dexlansoprazole and Esomeprazole Do Not Affect Bone Homeostasis in Healthy Postmenopausal Women
Karen E. Hansen et al.
GASTROENTEROLOGY (2019)
Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study
M. Amine Amiche et al.
ARCHIVES OF OSTEOPOROSIS (2018)
The limitations of using simple definitions of glucocorticoid exposure to predict fracture risk: A cohort study
Danielle E. Robinson et al.
BONE (2018)
Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study
Johanna H. M. Driessen et al.
DIABETES OBESITY & METABOLISM (2017)
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
Cindy Strehl et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Proton pump inhibitors and osteoporosis
Bjarne Nesgaard Andersen et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
ASSOCIATION OF PROTON PUMP INHIBITOR USE WITH RECURRENT FALLS AND RISK OF FRACTURES IN OLDER WOMEN: A STUDY OF MEDICATION USE IN OLDER FALLERS
H. W. Thaler et al.
JOURNAL OF NUTRITION HEALTH & AGING (2016)
A Proton Pump Inhibitor's Effect on Bone Metabolism Mediated by Osteoclast Action in Old Age: A Prospective Randomized Study
Yunju Jo et al.
GUT AND LIVER (2015)
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Emily Herrett et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
An algorithm to identify rheumatoid arthritis in primary care: a Clinical Practice Research Datalink study
Sara Muller et al.
BMJ OPEN (2015)
Long-Term Proton Pump Inhibitor Therapy and Falls and Fractures in Elderly Women: A Prospective Cohort Study
Joshua R. Lewis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Recent Safety Concerns With Proton Pump Inhibitors
Joan Chen et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Proton Pump Inhibitors and Risk of Fractures: A Meta-Analysis of 11 International Studies
Elaine W. Yu et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answers
F. de Vries et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
S. Pouwels et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Validity of diagnostic coding within the General Practice Research Database: a systematic review
Nada F. Khan et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2010)
Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis
Seo Young Kim et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates
F. de Vries et al.
OSTEOPOROSIS INTERNATIONAL (2009)
How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the General Practice Research Database?
S. L. Thomas et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Use of proton pump inhibitors and risk of osteoporosisrelated fractures
Laura E. Targownik et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
The epidemiology of glucocorticoid-associated adverse events
Allyson K. McDonough et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
FRAX™ and the assessment of fracture probability in men and women from the UK
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Fracture risk with intermittent high-dose oral glucocorticoid therapy
Frank de Vries et al.
ARTHRITIS AND RHEUMATISM (2007)
Long-term proton pump inhibitor therapy and risk of hip fracture
Yu-Xiao Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis
T. P. van Staa et al.
ARTHRITIS AND RHEUMATISM (2006)
Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture
P. Vestergaard et al.
CALCIFIED TISSUE INTERNATIONAL (2006)
Population-based assessment of adverse events associated with long-term glucocorticoid use
Jeffrey R. Curtis et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Effects of proton pump inhibitors on calcium carbonate absorption in women: A randomized crossover trial
MB O'Connell et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Epidemiology of osteoporotic fractures
Olof Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Glucocorticoids in the treatment of early and late RA
JWJ Bijlsma et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Bone loss in patients with rheumatoid arthritis - Results from a population-based cohort of 366 patients followed up for two years
G Haugeberg et al.
ARTHRITIS AND RHEUMATISM (2002)
Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland
TM Huusko et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Use of oral corticosteroids and risk of fractures
TP Van Staa et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
分享论文
